rupatadine

Ukraine

Drugs containing this active substance

  • BLIS®

    The drug is indicated for the symptomatic treatment of allergic rhinitis (including persistent) and urticaria in children aged 2 to 11 years.

    Form: solution, oral

    Active substance Dosage
    rupatadine 1 mg/ml

    ATC: R06AX28

    Manufacturer: Farmak JSC

  • BLIS®

    The drug is used for the symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents aged 12 years and older.

    Form: tablets

    Active substance Dosage
    rupatadine 10 mg

    ATC: R06AX28

    Manufacturer: Laboratorios Normon S.A. (manufacturing, primary packaging, secondary packaging, batch/quality control, batch release)

  • RUPAFIN

    The drug is used for the symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents aged 12 years and older.

    Form: tablets

    Active substance Dosage
    rupatadine 10 mg

    ATC: R06AX28

    Manufacturer: NOUCOR Health, S.A.

  • RUPAFIN

    The drug is used for the symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis) and urticaria in children aged 2 to 11 years.

    Form: solution, oral

    Active substance Dosage
    rupatadine 1 mg/ml

    ATC: R06AX28

    Manufacturer: Italfarmaco, S.A.